D-0661-2024 Class II Terminated

Recalled by Mckesson Medical-Surgical Inc. Corporate Office — Richmond, VA

FDA drug recall D-0661-2024 was initiated by Mckesson Medical-Surgical Inc. Corporate Office on Sep 11, 2024 and is designated Class II. Reason for recall: Temperature abuse: Products exposed to improper temperature above drug label specifications. The recall status is terminated (terminated Jan 29, 2025). Affected quantity: 27 bottles.

Recall Details

Product Type
Drugs
Report Date
Oct 2, 2024
Initiation Date
Sep 11, 2024
Termination Date
Jan 29, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27 bottles

Product Description

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06

Reason for Recall

Temperature abuse: Products exposed to improper temperature above drug label specifications.

Distribution Pattern

Product was distributed to two medical facilities in MD and VA.

Code Information

Lot # 476261, 479751, 479741, Exp 3/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0661-2024
openFDA file date
Oct 6, 2026
Loaded by RegDataLab
Oct 12, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it. FDA may have changed the recall since.